Reshape Lifesciences Inc
(RSLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 292 | 0 | 0 | 312 | 0 |
| Cost of Goods | 125 | N/A | N/A | 232 | N/A |
| Gross Profit | 167 | N/A | N/A | 80 | N/A |
| Operating Expenses | 28,159 | 25,593 | 24,734 | 22,861 | 25,257 |
| Operating Income | -27,867 | -25,593 | -24,734 | -22,549 | -25,257 |
| Interest Expense | 939 | 530 | 932 | 902 | 723 |
| Other Income | 3,307 | -5 | -114 | -9 | -18 |
| Pre-tax Income | -25,499 | -26,129 | -25,781 | -23,460 | -25,997 |
| Net Income Continuous | -25,499 | -26,129 | -25,781 | -23,460 | -25,997 |
| Net Income | $-25,499 | $-26,129 | $-25,781 | $-23,460 | $-25,997 |
| EPS Basic Total Ops | -298.97 | -404.25 | -7.03 | -0.59 | -0.86 |
| EPS Basic Continuous Ops | -298.97 | -404.25 | -7.03 | -0.59 | -0.86 |
| EPS Diluted Total Ops | -298.97 | -404.25 | -7.03 | -0.59 | -0.86 |
| EPS Diluted Continuous Ops | -298.97 | -404.25 | -7.03 | -0.59 | -0.86 |
| EBITDA(a) | $-26,852 | $-25,281 | $-24,360 | $-22,110 | $-24,715 |